Icon
+91 94997 68112
Login Register

BELEODAQ - (500mg/ vial; Powder, Intravenous)

BELINOSTAT Acrotech
500mg/ vial; Powder, Intravenous
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Used to treat relapsed or refracting peripheral T-cell lymphoma (PTCL)
Yes
********* ** ***. ********* **** ***** * **** ** *** *** *********. ** ****** **** **** ********* **** ****** ** *** ****. ******** ** ********* **** *********** ** *** *** ** ***-** *********** ********** ***** *** *, ****.
BELEODAQ Patent 1 Patent 2
********* **** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
********* **** *** \ ** ***** *, **** ******* **** ***** *** *, ****
  1. *** **, **** : ********* ******** ******** **** **** ** ***** **** **** ** *************.
  2. *** *, **** : ******** ***** * **** **** ******* '*** (*** ** ****), '*** (*** ** ****)
  3. *** *, **** : ******** (********) ******* **** ********* ****, ***** *** ***** ** ********** *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.